Insulet Corporation (PODD) has benefited from omnipod sales

Clearbridge InvestmentsInvestment Management Company issued an investor speech in the second quarter of the second quarter of the second quarter. It can be a copy of the message It was downloaded here. American stocks flourished strongly in the second quarter. The S&P 500 index has returned by 10.9 %, and the Russell 3000 Standard Index offers 11.0 %, with the risk continuing in the wake of the customs tariff. The strategy outperformed the standard in the quarter, driven by force in building governor through companies and sectors with distinguished developing engines. In addition, please check the five best holdings of the box to know its best choices in 2025.

In the investor’s speech in the second quarter of 2025, Clearbridge Select Strategy has highlighted the stocks such as Insulet Corporation (NASDAQ:pod). Insulet Corporation (NASDAQ: PODD) is developing and manufacturing insulin delivery systems. The return of Insulet Corporation (NASDAQ: PODD) for a month -1.72 %, and its shares have gained 35.57 % of its value over the past 52 weeks. On September 17, 2025, Insulet Corporation (NASDAQ: PODD) closed at $ 322.22 per share, with a marketing of a market of $ 22.682 billion.

The Clearbridge Select strategy mentioned the following regarding Insulet Corporation (NASDAQ: PODD) in the investor’s speech in the second quarter 2025:

“Our exposure to health care was prominent in a quarter of the witness’s comprehensive struggle due to the concerns of tariffs and challenges in the Medicare Advantage market. Insulting a company (NASDAQ: PODD), a developer of insulin pumps to treat diabetes, which was already witnessing a strong growth in the margin, benefiting from omnipod sales between the type 2 population, a market obtained by FDA’s approval last summer. “

Insulet Corporation (NASDAQ: PODD) is not listed on our list 30 shares more popular among hedge boxes. According to our database, 53 hedge clicks held Insulet Corporation (NASDAQ: PODD) at the end of the second quarter, compared to 47 in the previous quarter. Insulet Corporation’s (NASDAQ: PODD) the second quarter profit 32 % to $ 649 million. While we acknowledge the capabilities of Insulet Corporation (NASDAQ: PODD) as an investment, we believe that some of the artificial intelligence shares provide greater potential and carry less basic risks. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

In addition, please review Hedgement funds investor Q2 2025 A page for more investor messages from hedge funds and other prominent investors.